An Axendia Straight from the Source Event We asked FDA your questions about AI, CSA, and modern technology adoption. Now, we have the answers! In […]
Accelerating Modern Technology Adoption with CSA Read More »
An Axendia Straight from the Source Event AI is everywhere, but what are the steps to realizing value at scale? Spend 30 minutes with Daniel
Beyond the Hype: Achieving AI Value at Scale in Life Sciences Read More »
ValGenesis Innovations Days Event Brief ValConnect Innovation Days convened more than 30 life sciences organizations across Lisbon, Portugal, and Research Triangle Park, North Carolina, to
From Digital Validation to Intelligence Driven Operations Read More »
Veeva MedTech Summit 2026 Event Brief The Veeva MedTech Summit 2026 convened over 100 companies and more than 400 attendees in Chicago, Illinois. Seth Goldenberg,
Moving at the Speed of Trust Read More »
AI in Life Sciences: What the Industry Is Really Saying – The Pulse on Adoption, Opportunities, and Impact Artificial Intelligence is moving beyond experimentation and
New AI Market Research Report Read More »
AWS Life Sciences Symposium 2026 Event Brief The 2026 Annual AWS Life Sciences Symposium brought together more than two thousand leaders across biopharma, technology, and research to
AI at Scale will Reshape Life Sciences Read More »
A Propel Briefing Note Axendia was briefed by Erin Keefe, Director of Marketing and Communications, Tom Shoemaker, VP Product Marketing, and Chuck Serrin, VP Industry
The Right Tool for the Right Job Read More »
Axendia’s Analysis of the Root Causes and Our Recommendations to Prevent Them There has been a lot of buzz around FDA’s warning letter which for
FDA Calls Out Inappropriate Use of Artificial Intelligence Read More »
QAD Adaptive and Champion AI Briefing Note QAD Leadership including Tom Roberts, Vice President of Strategic Industry Development and Robyn Coward, Life Sciences Director, outlined
Moving from Systems of Record to Systems of Action Read More »
Medidata NEXT NY 2026 Event Brief The life sciences industry is navigating a period of continuous disruption driven by scientific complexity, operational pressure, regulatory modernization,
AI Agents and Virtual Twins Redefine the Future of Life Sciences Read More »
Axendia’s 8th Annual Life Sciences Industry Radar: “A Straight from the Source Event“ Turning Disruption into Competitive Advantage Axendia unveiled its 2026 Life Sciences Radar
2026 Life Sciences Radar: How to Turn Disruption into Competitive Advantage Read More »
Genari AI Briefing Note Axendia was briefed by Rosalind Beasley, Co-founder and CEO, and Tim Kirkelie, Co-founder and COO, at Genari AI. The company was
